--- title: "ADAPTIN BIO, INC. (APTN) stock: news and investor profile" url: "https://aibio.space/companies/adaptin-bio/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ADAPTIN BIO, INC. (OTC: APTN), United States. Listing facts, related biotech companies and news on aibio.space." --- APTN ADAPTIN BIO, INC. OTC · United States # ADAPTIN BIO, INC. (APTN) news Company Updates · 2026-08-20 ## [Adaptin Bio opens enrollment in Phase 1 trial of APTN-101 for glioblastoma](https://aibio.space/news/adaptin-bio-opens-enrollment-phase-1-trial-aptn-101-glioblastoma/) Adaptin Bio said on August 20, 2026 that enrollment has opened for a Phase 1 study of APTN-101 in patients with glioblastoma. The study is being conducted with Duke University and expects to enroll up to 15 adults. ## Latest ADAPTIN BIO, INC. news We have not published a story on ADAPTIN BIO, INC. yet. When there is news, it will appear here. ## ADAPTIN BIO, INC. at a glance - **Ticker**: APTN - **Listing**: OTC - **Country**: United States - **Cash, Jun 30, 2026**: $670,488 ### Related companies - [Edwards Lifesciences](https://aibio.space/companies/edwards-lifesciences/) NYSE: EW - [Revium Rx.](https://aibio.space/companies/revium-rx/) OTC: RVRC - [Inogen](https://aibio.space/companies/inogen/) NASDAQ: INGN - [SMITH & NEPHEW](https://aibio.space/companies/smith-nephew/) NYSE: SNN - [REVVITY, INC.](https://aibio.space/companies/revvity/) NYSE: RVTY - [UTAH MEDICAL PRODUCTS INC](https://aibio.space/companies/utah-medical-products/) NASDAQ: UTMD - [TELEFLEX INC](https://aibio.space/companies/teleflex/) NYSE: TFX - [Leef Brands](https://aibio.space/companies/leef-brands/) OTC: LEEEF ### Also on OTC - [TRAFALGAR INTERNATIONAL, INC.](https://aibio.space/companies/trafalgar-international-gcand/) GCAND - [PaxMedica](https://aibio.space/companies/paxmedica/) PXMD - [CV Sciences](https://aibio.space/companies/cv-sciences/) CVSI - [Avenir Wellness Solutions](https://aibio.space/companies/avenir-wellness-solutions/) AVRW - [Stimcell Energetics](https://aibio.space/companies/stimcell-energetics/) STME - [Cannaisseur Group](https://aibio.space/companies/cannaisseur/) TCRG ## ADAPTIN BIO, INC. annual financials | Line | FY2025 | FY2024 | |---|---|---| | Research and development | [$1.8 million](https://www.sec.gov/Archives/edgar/data/1938571/000121390026038568/) | [$1.8 million](https://www.sec.gov/Archives/edgar/data/1938571/000121390026038568/) | | Net income (loss) | [-$5.2 million](https://www.sec.gov/Archives/edgar/data/1938571/000121390026038568/) | [-$3.1 million](https://www.sec.gov/Archives/edgar/data/1938571/000121390026038568/) | | Cash from operations | [-$4.8 million](https://www.sec.gov/Archives/edgar/data/1938571/000121390026038568/) | [-$649,283](https://www.sec.gov/Archives/edgar/data/1938571/000121390026038568/) | | Cash and equivalents | [$459,174](https://www.sec.gov/Archives/edgar/data/1938571/000121390026089081/) | [$34,085](https://www.sec.gov/Archives/edgar/data/1938571/000121390026038568/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $670,488. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about ADAPTIN BIO, INC. What is the ticker symbol of ADAPTIN BIO, INC.? ADAPTIN BIO, INC. trades under the ticker APTN on OTC. Where is ADAPTIN BIO, INC. listed? ADAPTIN BIO, INC. is listed on OTC. Which country or territory is ADAPTIN BIO, INC. listed under? Our directory records ADAPTIN BIO, INC. under United States. Does aibio.space cover ADAPTIN BIO, INC.? aibio.space lists ADAPTIN BIO, INC. among 2,820 public biotech companies and publishes its news here as stories appear. Is ADAPTIN BIO, INC. profitable? ADAPTIN BIO, INC. reported a net loss of $5.2 million for the fiscal year ended Dec 31, 2025, and used $4.8 million of cash in operations, per its annual report to the SEC. How much does ADAPTIN BIO, INC. spend on research and development? $1.8 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does ADAPTIN BIO, INC. have? $670,488 in cash at Jun 30, 2026, per its 10-Q. What is the latest ADAPTIN BIO, INC. (APTN) stock news? Our latest story on ADAPTIN BIO, INC., dated Aug 20, 2026: "Adaptin Bio opens enrollment in Phase 1 trial of APTN-101 for glioblastoma". Adaptin Bio said on August 20, 2026 that enrollment has opened for a Phase 1 study of APTN-101 in patients with glioblastoma. The study is being conducted with Duke University and expects to enroll up to 15 adults. [Source](https://aibio.space/news/adaptin-bio-opens-enrollment-phase-1-trial-aptn-101-glioblastoma/). How long will ADAPTIN BIO, INC.'s cash last? From our story of Aug 20, 2026: The release lists, among its risks, the company's ability to raise additional money to fund its operations for at least the next 12 months as a going concern. [Source](https://aibio.space/news/adaptin-bio-opens-enrollment-phase-1-trial-aptn-101-glioblastoma/). How can I follow ADAPTIN BIO, INC. (APTN) news? Press Follow on this page to add ADAPTIN BIO, INC. to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming ADAPTIN BIO, INC. so far, in Company Updates. ## Investor discussion: ADAPTIN BIO, INC. Members talk about ADAPTIN BIO, INC. (APTN). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at ADAPTIN BIO, INC., newest first. Each line links the filing it comes from. 1. 2026-08-28 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/1938571/000121390026095034/ea0303043-s1_adaptin.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open OTC:APTN on TradingView](https://www.tradingview.com/symbols/OTC-APTN/). ## Listing details ADAPTIN BIO, INC. is a public biotech or pharmaceutical company listed on OTC under the ticker APTN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: ADAPTIN BIO, INC. - **Ticker**: APTN - **Listing**: OTC - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/adaptin-bio/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "ADAPTIN BIO, INC. (APTN) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/adaptin-bio/